Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Purdue Execs Plead Guilty To Misbranding OxyContin; Company Pays $700 Mil.

Related Content

OxyContin Ads Will Highlight Boxed Warning In Response To FDA Objection

Jan 27 2003

Serostim $704 Mil. Settlement Is Largest For Off-Label Marketing Case

Oct 24 2005

Warner-Lambert GMP Conviction Plays Role In Neurontin Case

May 17 2004

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window